<DOC>
	<DOCNO>NCT03075215</DOCNO>
	<brief_summary>To learn general Cardiac Resynchronization Therapy Defibrillators ( CRT-D ) population , optimization technique use effective . It compare 12-month response rate among different optimization method characterize select subject subgroup achieve good response others . A subset SMART Registry subject contribute NG4 Post Market Clinical Follow Up ( PMCF ) Cohort whose objective collecting data NG4 CRT-D feature device usage real world set monitor long term safety associate device support CE Mark .</brief_summary>
	<brief_title>Strategic MAnagement Optimize Response To Cardiac Resynchronization Therapy Registry</brief_title>
	<detailed_description />
	<mesh_term>Heart Failure</mesh_term>
	<criteria>Subject implant upgraded NG3 NG4 CRTD device connect manufacturer quadripolar LV lead base BSC label device specific geography . Subjects must enrol 1 21 calendar day post CRTD implantation procedure . Subject age 18 , legal age give inform consent specific country national law Subject willing capable comply followup visit procedure define protocol Subject document life expectancy le 12 month Subject currently active heart transplant list current Left Ventricular Assist Device assist device ( mechanical circulatory support device ) . Subject preexist CRT device Subject enrol concurrent clinical trial without prior write approval BSC Clinical Trial Manager Women childbearing potential might pregnant time study enrolment Any contraindication receive CRTD device per local guideline</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>